Wealth Awesome Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 1335
- Sources here
- 15
- Companies here
- 20
Active search
1335 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Got $200? 1 Quantum Computing ETF to Buy Right Now.
If you have $200 and want to point it at something that feels like the future, Defiance Quantum ETF (NASDAQ: QTUM) is a serious contender instead of a science project. When you buy this ETF, you're buying a basket of companies that are already …
Sharemaestro market context Price above Trend Line 52 weeks +16.5%Brighthouse Financial Announces Preferred Stock Dividends and Related Depositary Share Distributions
CHARLOTTE, N.C., August 17, 2026--(BUSINESS WIRE)--Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today that on September 25, 2026, holders of record as of September 10, 2026 (the "Record Date") of (i) its depositary shares (the "Series A Depositary Shares" (Nasdaq: …
Sharemaestro market context Trend signal ended 52 weeks +24.6% · Next-week setup positive 58.6%Oppenheimer Asset Management Inc. Invests $5.87 Million in Keurig Dr Pepper, Inc $KDP
Oppenheimer Asset Management Inc. recently acquired a new stake of 179,480 shares in Keurig Dr Pepper, Inc (NASDAQ:KDP), valued at approximately $5.87 million during the second quarter. This move is part of broader institutional investment trends, with other major firms like Vanguard Group Inc. …
Curtiss Wright (CW) Stock Looks Stretched Following Its 5x Five Year Run
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Curtiss-Wright stock has delivered a very large 5 year return, yet current valuation checks suggest the shares now trade at a premium to an intrinsic value estimate …
Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope
Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …
Curtiss-Wright (CW) Just Raised Guidance Again, So What’s The Catch?
On August 6, Curtiss-Wright (NYSE:CW) held its second quarter 2026 earnings call and reported that the company's sales climbed 5% year-over-year to $924 million, but the real story was underneath. Operating income grew 12%, more than double the pace of revenue, pushing margins up …
Curtiss Wright (CW) Earnings Beat Puts Fair Value Back In Focus
Curtiss-Wright (CW) recently reported strong Q2 2026 earnings, surpassing expectations and raising full-year guidance, which has positively impacted its stock price. The company's fair value is estimated to be around $814.83 per share, indicating it is currently undervalued despite its strong P/E ratio. Investors …
Avoiding Lag: Real-Time Signals in (BTSG) Movement
This article provides a real-time analysis of Brightspring Health Services Inc. (NASDAQ: BTSG), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The …
Transocean Share Surge Narrows Gap to Analyst Consensus View
Transocean (NYSE:RIG) shares gained 0.7% on Friday, closing at $5.76, despite underperforming the broader S&P 500 energy sector. The stock's current price is 11.2% below the analyst consensus target of $6.40, indicating a narrowing gap. The company's proposed acquisition of Valaris Ltd. (NYSE:VAL) and …
Walleye Capital LLC Takes Position in Curtiss-Wright Corporation $CW
Walleye Capital LLC has acquired a new stake of 4,412 shares in Curtiss-Wright Corporation, valued at approximately $3.34 million. This move is part of broader institutional interest, with several other funds also adjusting their positions in the aerospace company. Curtiss-Wright recently exceeded quarterly earnings …
Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands
Madrigal Pharmaceuticals' drug Rezdiffra achieved a $1.3 billion trailing-12-month revenue run rate in Q2 2026, with revenue up 71% year-over-year and over 49,000 active patients. The company is expanding its MASH pipeline to 10 assets, primarily for combination with Rezdiffra, targeting weight loss, liver-fat …
Assenagon Asset Management S.A. Sells 216,061 Shares of Keurig Dr Pepper, Inc $KDP
Assenagon Asset Management S.A. significantly reduced its stake in Keurig Dr Pepper (NASDAQ:KDP) by 82.7% in the second quarter, selling 216,061 shares. Following the sale, the firm now owns 45,040 shares valued at $1.47 million. Other institutional investors have shown mixed activity, with some …
(RIGL) Price Dynamics and Execution-Aware Positioning
This article analyzes Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) focusing on its price dynamics and execution-aware positioning based on AI models. It identifies strong near and mid-term sentiment, compelling upside potential due to a lack of resistance levels above the current price, and outlines specific …
Licensable picture: The logo of Origin Agritech is seen at the company's headquarters in Beijing
This article features a licensable picture of the Origin Agritech logo, taken at the company's headquarters in Beijing on November 27, 2015. The image is credited to REUTERS/Kim Kyung-Hoon and details its dimensions, size, and source information. The content is primarily an image description …
Bright Minds Biosciences (NASDAQ:DRUG) Issues Quarterly Earnings Results
Bright Minds Biosciences (NASDAQ:DRUG) reported quarterly earnings per share of ($0.17), significantly surpassing analysts' consensus estimate of ($1.28). Following the announcement, shares fell 2.0% to $76.44. Analysts maintain a generally positive outlook on the stock, with an average "Buy" rating and a consensus price …